scispace - formally typeset
A

Ambuja Navalkar

Researcher at Indian Institute of Technology Bombay

Publications -  29
Citations -  840

Ambuja Navalkar is an academic researcher from Indian Institute of Technology Bombay. The author has contributed to research in topics: Amyloid & Medicine. The author has an hindex of 10, co-authored 23 publications receiving 391 citations.

Papers
More filters
Journal ArticleDOI

α-Synuclein aggregation nucleates through liquid-liquid phase separation.

TL;DR: In vitro generated α-Syn liquid-like droplets eventually undergo a liquid-to-solid transition and form an amyloid hydrogel that contains oligomers and fibrillar species and this work provides detailed insights into the phase-separation behaviour of natively unstructured α- Syn and its conversion to a disease-associated aggregated state, which is highly relevant in Parkinson's disease pathogenesis.
Journal ArticleDOI

p53 amyloid formation leading to its loss of function: implications in cancer pathogenesis

TL;DR: In vitro studies show that cancer-associated mutation destabilizes the fold of p53 core domain and also accelerates the aggregation and amyloid formation by this protein, suggesting that inhibiting p53 isyloidogenesis could restore p53 tumor suppressor functions.
Journal ArticleDOI

Lipopolysaccharide from Gut Microbiota Modulates α-Synuclein Aggregation and Alters Its Biological Function.

TL;DR: Biophysical techniques in conjunction with microscopic images revealed the molecular interaction between lipopolysaccharide and α-synuclein that induce rapid nucleation events and characterizes this heteromolecular interaction associated with an alternative pathway in Parkinson's disease progression.
Journal ArticleDOI

Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors

TL;DR: The present study suggests that sequence based interaction of small molecules with soluble α-Syn might dictate their inhibition or modulation capacity, which might be helpful in designing modulators of α- synuclein aggregation.
Journal ArticleDOI

Prion-like p53 Amyloids in Cancer.

TL;DR: An insight into understanding p53 as a prion-like protein is provided and cancer to be recognized as amyloid or prions-like disease is proposed.